ACURA PHARMACEUTICALS, INC·4

Jan 5, 9:22 AM ET

SUMNER WILLIAM 4

4 · ACURA PHARMACEUTICALS, INC · Filed Jan 5, 2010

Insider Transaction Report

Form 4
Period: 2010-01-04
Transactions
  • Award

    Director Stock Options

    2010-01-04+15,00015,000 total
    Exercise: $5.47Exp: 2020-01-03Common Stock (15,000 underlying)
Footnotes (3)
  • [F1]Exercise price is closing price of Issuer's common stock on January 4, 2010.
  • [F2]Twenty-five percent (25%) of shares underlying options vest on, and are exercisable commencing, each of March 31, 2010, June 30, 2010, September 30, 2010 and December 31, 2010.
  • [F3]Not Applicable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION